Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Physical activity in leisure time and at work and risk of dementia: A prospective cohort study of 117,616 individuals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Lipoprotein(a) during COVID-19 hospitalization: Thrombosis, inflammation, and mortality

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Socioeconomic disparity in cardiovascular disease: Possible biological pathways based on a proteomic approach

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Association of apolipoprotein M and sphingosine-1-phosphate with brown adipose tissue after cold exposure in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Apolipoprotein M (apoM) is a member of the lipocalin superfamily and is predominantly associated with high-density lipoprotein (HDL). It was found that apoM is the chaperon to the bioactive sphingolipid, sphingosine-1-phosphate (S1P). Several studies have since contributed to expand the knowledge on apoM, S1P, and the apoM/S1P-complex in cardiovascular diseases. For instance, the HDL-bound apoM/S1P complex serves as a bridge between HDL and endothelial cells, maintaining a healthy endothelial barrier. Evidence indicates, however, that the apoM/S1P complex may has both protective and harmful effects on the cardiovascular system, which suggests the need for more research to understand the interplay between these molecules. This review aims to shed light on the most recent findings on apoM/S1P-signaling and its impact on endothelial dysfunction, inflammation, and cardiovascular diseases. Finally, it will be discussed whether drugs that target apoM and/or S1P-signaling may be beneficial to patients with cardiovascular and inflammatory diseases.

OriginalsprogEngelsk
TidsskriftAtherosclerosis
Vol/bind334
Sider (fra-til)76-84
Antal sider9
ISSN0021-9150
DOI
StatusUdgivet - okt. 2021

ID: 67567835